Adenia Partners to acquire a majority stake in Parkville Pharmaceuticals from Admaius Capital Partners.

Adenia Partners, a private equity firm, agreed to acquire a majority stake in Parkville Pharmaceuticals, a pharmaceutical company that manufactures and distributes unique products in the Egyptian pharmaceutical market, from Admaius Capital Partners, an Africa-focused private equity investor. Financial terms were not disclosed. “We are delighted our first acquisition in Egypt is into one of the region’s fastest growing businesses. We see tremendous potential in Parkville’s mission to expand access to affordable, high-quality health and personal care products,"téphane Bacquaert, Adenia Partners Managing Partner.